Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Elevance Health (ELV) Stock Price & Analysis

ELV Stock Chart & Stats

$409.92-$10.15(-2.42%)
At close: 11:28 AM EST
$375$400$4253 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$416.47 - $426.77
52-Week Range
$274.84 - $450.69
Previous Close
$422.02
Volume
N/A
Average Volume (3M)
1.29M
Market Cap
$90.76B
Enterprise Value
$115.48B
Total Cash (Recent Filing)
$37.85B
Total Debt (Recent Filing)
$30.76B
Price to Earnings (P/E)
17.9
Beta
0.44
Next Earnings
Jan 27, 2027 (Est.)
EPS Estimate
2.08
Next Dividend Ex-Date
Dec 04, 2026
Dividend Yield
1.64%

Bulls Say, Bears Say

Bulls Say

Strong Cash Generation

The sharp free-cash-flow rebound and strong conversion from earnings provide internal funding for investments, dividends, and other capital priorities. This cash capacity improves resilience across underwriting cycles and supports Carelon expansion without relying excessively on external financing.

Carelon Growth Platform

Carelon adds a services-led growth engine alongside insurance premiums, helping diversify revenue and extend Elevance’s healthcare capabilities to external customers. High retention, new wins, and a broad pipeline indicate that the platform can support recurring growth beyond membership changes.

Integrated Healthcare Value

Combining medical and pharmacy capabilities can produce measurable savings and lower emergency-room use, strengthening the value proposition for members, employers, and health plans. Demonstrated clinical and cost outcomes can support retention, contracting power, and broader adoption of Elevance’s integrated model.

Bears Say

Persistent Margin Compression

Multi-year margin erosion means revenue growth is not translating proportionally into earnings, leaving less buffer against medical-cost volatility. If profitability remains compressed, Elevance may have less flexibility to invest, absorb adverse claims development, or improve returns while maintaining competitive pricing.

Medicaid Cost And Rate Pressure

When reimbursement rates lag healthcare costs, Medicaid margins remain vulnerable even if utilization and care-management actions improve. The expected recovery depends on future rate alignment, while work requirements and membership changes may add acuity uncertainty and prolong pressure on this business.

ACA Risk-pool Normalization

A prolonged ACA risk-pool adjustment can create uncertainty in member mix, risk adjustment, and claims economics across multiple renewal cycles. The shift toward lower-premium bronze plans may pressure profitability and require continued pricing, retention, and underwriting discipline.

Elevance Health News

ELV FAQ

What was Elevance Health’s price range in the past 12 months?
Elevance Health lowest stock price was $274.84 and its highest was $450.69 in the past 12 months.
What is Elevance Health’s market cap?
Elevance Health’s market cap is $90.76B.
When is Elevance Health’s upcoming earnings report date?
Elevance Health’s next earnings report is estimated for Jan 27, 2027 (not yet confirmed), which is in 85 days.
How were Elevance Health’s earnings last quarter?
Elevance Health released its earnings results on Oct 21, 2026. The company reported $6.99 earnings per share for the quarter, beating the consensus estimate of $4.714 by $2.276.
Is Elevance Health overvalued?
According to Wall Street analysts Elevance Health’s price is currently Undervalued.
Does Elevance Health pay dividends?
Elevance Health pays a Quarterly dividend of $1.72 which represents an annual dividend yield of 1.64%. See more information on Elevance Health dividends here
What is Elevance Health’s EPS estimate?
Elevance Health’s EPS estimate is 2.08.
How many shares outstanding does Elevance Health have?
Elevance Health has 216,055,900 shares outstanding.
What happened to Elevance Health’s price movement after its last earnings report?
Elevance Health reported an EPS of $6.99 in its last earnings report, beating expectations of $4.714. Following the earnings report the stock price went down -1.374%.
Which hedge fund is a major shareholder of Elevance Health?
Hedge funds hold Elevance Health shares: the largest hedge-fund position in Elevance Health is 71,887,511 shares, and hedge funds decreased their holdings by 1.2M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology